United States Antiandrogen Monotherapy Market Report 2016

September 2016 | 121 pages | ID: UFA4CCF14FBEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antiandrogen Monotherapy

Revenue, means the sales value of Antiandrogen Monotherapy

This report studies sales (consumption) of Antiandrogen Monotherapy in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer Inc. (USA)
• Abbott Laboratories (USA)
• Genentech Inc. (USA)
• GlaxoSmithKline Plc (UK)
• Immunomedics, Inc. (USA)
• Indevus Pharmaceuticals Inc. (USA)
• Novartis AG (Switzerland)
• OSI Pharmaceuticals, Inc. (USA)
• Paladin Labs Inc. (Canada)
• ALZA Corporation (USA)
• Amgen Inc. (USA)
• AstraZeneca PLC (UK)
• Medimmune, LLC (USA)
• Bristol-Myers Squibb Company (USA)
• Cell Genesys Inc. (USA)
• Dendreon Corporation (USA)
• EUSA Pharma, (USA) Inc. (USA)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Progenics Pharmaceuticals, Inc. (USA)
• Sanofi-Aventis SA (France)
• Spectrum Pharmaceuticals, Inc. (USA)
• Takeda Pharmaceutical Company Limited (Japan)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Antiandrogen Monotherapy in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Antiandrogen Monotherapy Market Report 2016

1 ANTIANDROGEN MONOTHERAPY OVERVIEW

1.1 Product Overview and Scope of Antiandrogen Monotherapy
1.2 Classification of Antiandrogen Monotherapy
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Antiandrogen Monotherapy
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Antiandrogen Monotherapy (2011-2021)
  1.4.1 USA Antiandrogen Monotherapy Sales and Growth Rate (2011-2021)
  1.4.2 USA Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)

2 USA ANTIANDROGEN MONOTHERAPY COMPETITION BY MANUFACTURERS

2.1 USA Antiandrogen Monotherapy Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Antiandrogen Monotherapy Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Antiandrogen Monotherapy Average Price by Manufactures (2015 and 2016)
2.4 Antiandrogen Monotherapy Market Competitive Situation and Trends
  2.4.1 Antiandrogen Monotherapy Market Concentration Rate
  2.4.2 Antiandrogen Monotherapy Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA ANTIANDROGEN MONOTHERAPY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Antiandrogen Monotherapy Sales and Market Share by Type (2011-2016)
3.2 USA Antiandrogen Monotherapy Revenue and Market Share by Type (2011-2016)
3.3 USA Antiandrogen Monotherapy Price by Type (2011-2016)
3.4 USA Antiandrogen Monotherapy Sales Growth Rate by Type (2011-2016)

4 USA ANTIANDROGEN MONOTHERAPY SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Antiandrogen Monotherapy Sales and Market Share by Application (2011-2016)
4.2 USA Antiandrogen Monotherapy Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA ANTIANDROGEN MONOTHERAPY MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer Inc. (USA)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Antiandrogen Monotherapy Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Abbott Laboratories (USA)
  5.2.2 Antiandrogen Monotherapy Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Abbott Laboratories (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Genentech Inc. (USA)
  5.3.2 Antiandrogen Monotherapy Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Genentech Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 GlaxoSmithKline Plc (UK)
  5.4.2 Antiandrogen Monotherapy Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Immunomedics, Inc. (USA)
  5.5.2 Antiandrogen Monotherapy Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Immunomedics, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Indevus Pharmaceuticals Inc. (USA)
  5.6.2 Antiandrogen Monotherapy Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Novartis AG (Switzerland)
  5.7.2 Antiandrogen Monotherapy Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Novartis AG (Switzerland) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 OSI Pharmaceuticals, Inc. (USA)
  5.8.2 Antiandrogen Monotherapy Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Paladin Labs Inc. (Canada)
  5.9.2 Antiandrogen Monotherapy Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 ALZA Corporation (USA)
  5.10.2 Antiandrogen Monotherapy Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 ALZA Corporation (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Amgen Inc. (USA)
5.12 AstraZeneca PLC (UK)
5.13 Medimmune, LLC (USA)
5.14 Bristol-Myers Squibb Company (USA)
5.15 Cell Genesys Inc. (USA)
5.16 Dendreon Corporation (USA)
5.17 EUSA Pharma, (USA) Inc. (USA)
5.18 F. Hoffmann-La Roche Ltd. (Switzerland)
5.19 Progenics Pharmaceuticals, Inc. (USA)
5.20 Sanofi-Aventis SA (France)
5.21 Spectrum Pharmaceuticals, Inc. (USA)
5.22 Takeda Pharmaceutical Company Limited (Japan)

6 ANTIANDROGEN MONOTHERAPY MANUFACTURING COST ANALYSIS

6.1 Antiandrogen Monotherapy Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Antiandrogen Monotherapy

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Antiandrogen Monotherapy Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA ANTIANDROGEN MONOTHERAPY MARKET FORECAST (2016-2021)

10.1 USA Antiandrogen Monotherapy Sales, Revenue Forecast (2016-2021)
10.2 USA Antiandrogen Monotherapy Sales Forecast by Type (2016-2021)
10.3 USA Antiandrogen Monotherapy Sales Forecast by Application (2016-2021)
10.4 Antiandrogen Monotherapy Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antiandrogen Monotherapy
Table Classification of Antiandrogen Monotherapy
Figure USA Sales Market Share of Antiandrogen Monotherapy by Type in 2015
Table Application of Antiandrogen Monotherapy
Figure USA Sales Market Share of Antiandrogen Monotherapy by Application in 2015
Figure USA Antiandrogen Monotherapy Sales and Growth Rate (2011-2021)
Figure USA Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Table USA Antiandrogen Monotherapy Sales of Key Manufacturers (2015 and 2016)
Table USA Antiandrogen Monotherapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antiandrogen Monotherapy Sales Share by Manufacturers
Figure 2016 Antiandrogen Monotherapy Sales Share by Manufacturers
Table USA Antiandrogen Monotherapy Revenue by Manufacturers (2015 and 2016)
Table USA Antiandrogen Monotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Antiandrogen Monotherapy Revenue Share by Manufacturers
Table 2016 USA Antiandrogen Monotherapy Revenue Share by Manufacturers
Table USA Market Antiandrogen Monotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Antiandrogen Monotherapy Average Price of Key Manufacturers in 2015
Figure Antiandrogen Monotherapy Market Share of Top 3 Manufacturers
Figure Antiandrogen Monotherapy Market Share of Top 5 Manufacturers
Table USA Antiandrogen Monotherapy Sales by Type (2011-2016)
Table USA Antiandrogen Monotherapy Sales Share by Type (2011-2016)
Figure USA Antiandrogen Monotherapy Sales Market Share by Type in 2015
Table USA Antiandrogen Monotherapy Revenue and Market Share by Type (2011-2016)
Table USA Antiandrogen Monotherapy Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antiandrogen Monotherapy by Type (2011-2016)
Table USA Antiandrogen Monotherapy Price by Type (2011-2016)
Figure USA Antiandrogen Monotherapy Sales Growth Rate by Type (2011-2016)
Table USA Antiandrogen Monotherapy Sales by Application (2011-2016)
Table USA Antiandrogen Monotherapy Sales Market Share by Application (2011-2016)
Figure USA Antiandrogen Monotherapy Sales Market Share by Application in 2015
Table USA Antiandrogen Monotherapy Sales Growth Rate by Application (2011-2016)
Figure USA Antiandrogen Monotherapy Sales Growth Rate by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information List
Table ALZA Corporation (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table ALZA Corporation (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Amgen Inc. (USA) Basic Information List
Table Amgen Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table AstraZeneca PLC (UK) Basic Information List
Table AstraZeneca PLC (UK) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca PLC (UK) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Medimmune, LLC (USA) Basic Information List
Table Medimmune, LLC (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medimmune, LLC (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Bristol-Myers Squibb Company (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Cell Genesys Inc. (USA) Basic Information List
Table Cell Genesys Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cell Genesys Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Dendreon Corporation (USA) Basic Information List
Table Dendreon Corporation (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon Corporation (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Basic Information List
Table EUSA Pharma, (USA) Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List
Table Progenics Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Sanofi-Aventis SA (France) Basic Information List
Table Sanofi-Aventis SA (France) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Aventis SA (France) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List
Table Spectrum Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Antiandrogen Monotherapy Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen Monotherapy
Figure Manufacturing Process Analysis of Antiandrogen Monotherapy
Figure Antiandrogen Monotherapy Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2015
Table Major Buyers of Antiandrogen Monotherapy
Table Distributors/Traders List
Figure USA Antiandrogen Monotherapy Production and Growth Rate Forecast (2016-2021)
Figure USA Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2016-2021)
Table USA Antiandrogen Monotherapy Production Forecast by Type (2016-2021)
Table USA Antiandrogen Monotherapy Consumption Forecast by Application (2016-2021)